Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Immunology
IF: 1.352 5-Year IF: 3.347 SJR: 1.022 SNIP: 0.55 CiteScore™: 2.19

ISSN Print: 1040-8401
ISSN Online: 2162-6472

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v24.i2.10
24 pages

Regulation of Lymphoid Cell Apoptosis by Jaks and Stats

Zsuzsanna S. Nagy
University of Texas Health Science Center at Houston, Department of Integrative Biology and Pharmacology, MSB Rm 4.218, Houston, TX 77030
Jeremy Ross
University of Texas Health Science Center at Houston, Department of Integrative Biology and Pharmacology, MSB Rm 4.218, Houston, TX 77030
Hanyin Cheng
University of Texas Health Science Center at Houston, Department of Integrative Biology and Pharmacology, MSB Rm 4.218, Houston, TX 77030
Stanislaw M. Stepkowski
University of Texas Health Science Center at Houston, Department of Surgery, Division of Organ Transplantation, MSB Rm 4.218, Houston, TX 77030
Robert A. Kirken
University of Texas—Houston, Department of Integrative Biology and Pharmacology, MSB Rm 4.218, Houston, TX 77030

ABSTRACT

Regulation of T- and B-lymphocyte survival and death is crucial for maintaining immune homeostasis. Unresponsiveness to death signals can result in lymphoproliferative disorders including cancer and autoimmunity, whereas lymphocytes hypersensitive to such signals can be manifested as immunodeficiencies. Often within these cells, cytokines and their receptors regulate the critical balance between life and death. It is becoming ever more apparent that within these effector cascades, Janus tyrosine kinases (Jak) and signal transducers and activators of transcription (Stat) act as key regulatory components. Invaluable knowledge about Jaks and Stats has arisen from mice made genetically deficient in these molecules, tumor models, and proteomics/genomics, which has begun to define their role in survival versus apoptosis. These findings have also suggested how Jaks and Stats might be manipulated for therapeutic intervention in lymphoid-derived diseases. This review seeks to focus on the role of Jak tyrosine kinases and Stat transcription factors in mediating the lymphocyte life cycle.


Articles with similar content:

Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases
Critical Reviews™ in Immunology, Vol.35, 2015, issue 6
Yudong Liu, Etty N. Benveniste, Hongwei Qin, Sara A. Gibson
Tissue-Specific Transformation by Oncogenic Mutants of Epidermal Growth Factor Receptor
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 4
H. J. Kung, T. H. Carter
Thymus-Derived Signals Regulate Early T-Cell Development
Critical Reviews™ in Immunology, Vol.25, 2005, issue 2
Thomas M. Schmitt, Juan Carlos Zuniga-Pflucker
Post-Translational Regulation of Fas/CD95 in Cell Death and Survival: Role of Nitric Oxide
Forum on Immunopathological Diseases and Therapeutics, Vol.1, 2010, issue 4
Ali Bettaieb, Jean-Francois Jeannin, L. Leon-Bollotte, S. Plenchette-Colas, M. Lamrani
Steel Factor and c-kit Protooncogene: Genetic Lessons in Signal Transduction
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 2-3
Janna M. Blechman, David Givol, Yosef Yarden, Sima Lev